Mass isotopomer-guided decluttering of metabolomic data to visualize endogenous biomarkers of drug toxicity

Biochemical Pharmacology
Diren BeyoğluJeffrey R Idle

Abstract

Metabolomics offers the opportunity to uncover endogenous biomarkers that can lead to metabolic pathways and networks and that underpin drug toxicity mechanisms. A novel protocol is presented and discussed that is applicable to drugs which generate urinary metabolites when administered to mice sensitive to its toxicity. The protocol would not apply to drugs that are not metabolized or eliminated by a different route. Separate stable isotope-labeled and unlabeled drug administration to mice is made together with collection of urines from control animals. Untargeted mass spectrometry-based metabolomic analysis of these three urine groups is conducted in addition to principal components analysis (PCA). In the case of unlabeled acetaminophen and [acetyl-2H3]acetaminophen, each given at a hepatotoxic dose (400 mg/kg i.p.) to the sensitive mouse strain (wild-type 129), the PCA loadings plot showed a distribution of ions in the shape of a "fallen-Y" with the deuterated metabolites in one arm and the paired nondeuterated metabolites in the other arm of the fallen-Y. Ions corresponding to the endogenous toxicity biomarkers sat in the mouth of the fallen-Y. This protocol represents an innovative means to separate endogenous biomarkers fr...Continue Reading

References

Jan 1, 1976·The Journal of International Medical Research·R S AndrewsK Watson
May 1, 1991·Biochemical Pharmacology·N E PreeceJ A Timbrell
Mar 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H SugimotoS Matsuzaki
Apr 15, 1983·Biochemical and Biophysical Research Communications·E T MorganM J Coon
Sep 28, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·D G RobertsonT K Braden
Nov 4, 2000·Nature Biotechnology·O FiehnL Willmitzer
Apr 5, 2001·Trends in Microbiology·G H Thomas
Jul 5, 2001·Toxicology and Applied Pharmacology·B J Bray, R J Rosengren
Jan 16, 2002·JAMA : the Journal of the American Medical Association·David W KaufmanAllen A Mitchell
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Laura P JamesJack A Hinson
Jul 27, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Wouter H MoolenaarBen N G Giepmans
Sep 24, 2004·Rapid Communications in Mass Spectrometry : RCM·Robert PlumbAndrew Wright
Dec 1, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anne M LarsonUNKNOWN Acute Liver Failure Study Group
Jan 13, 2006·Therapeutic Drug Monitoring·Colin A SmithGary Siuzdak
Jun 20, 2006·Chemical Research in Toxicology·Sarbani GiriFrank J Gonzalez
Oct 6, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Frank J Gonzalez
Jul 3, 2009·Journal of Proteome Research·Andrew D PattersonJeffrey R Idle
Apr 7, 2011·Journal of Clinical Pharmacy and Therapeutics·R HudecJ Tisoňová
Feb 4, 2012·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Soo Hyun LeeByung Hwa Jung
Sep 1, 2012·Biochemical Pharmacology·Diren Beyoğlu, Jeffrey R Idle
Mar 7, 2013·Pharmaceutical Research·Mitchell R McGill, Hartmut Jaeschke
May 21, 2014·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Edward TakachHanlan Liu
Apr 3, 2016·Current Protocols in Molecular Biology·Oliver Fiehn
Jul 16, 2016·Experimental & Molecular Medicine·Sang-Min Jeon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.